This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

CIPA Life Sciences: How to navigate the EPO boards of appeal


The European Patent Office boards of appeal are unlikely to be able to reduce the case backlog anytime soon, but attorneys should be wary of possible changes in board practice, former board head Alec Clelland told the Chartered Institute of Patent Attorneys (CIPA) Life Sciences conference.

CIPA Life Sciences, EPO boards of appeal, European Patent Office, Alec Clelland


Payment types accepted